Correlation Between Merck and Pharvaris

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Pharvaris BV, you can compare the effects of market volatilities on Merck and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Pharvaris.

Diversification Opportunities for Merck and Pharvaris

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Merck and Pharvaris is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Merck i.e., Merck and Pharvaris go up and down completely randomly.

Pair Corralation between Merck and Pharvaris

Considering the 90-day investment horizon Merck Company is expected to under-perform the Pharvaris. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 3.06 times less risky than Pharvaris. The stock trades about -0.11 of its potential returns per unit of risk. The Pharvaris BV is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,771  in Pharvaris BV on September 1, 2024 and sell it today you would earn a total of  419.00  from holding Pharvaris BV or generate 23.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Pharvaris BV

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Pharvaris BV 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.

Merck and Pharvaris Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Pharvaris

The main advantage of trading using opposite Merck and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.
The idea behind Merck Company and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Transaction History
View history of all your transactions and understand their impact on performance